• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.

作者信息

Kanakry Christopher G, Luznik Leo

机构信息

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Biol Blood Marrow Transplant. 2018 Jun;24(6):1108-1110. doi: 10.1016/j.bbmt.2018.04.004. Epub 2018 Apr 10.

DOI:10.1016/j.bbmt.2018.04.004
PMID:29653207
Abstract
摘要

相似文献

1
Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.让老狗学新招：对移植后环磷酰胺单倍体相合移植平台的改良
Biol Blood Marrow Transplant. 2018 Jun;24(6):1108-1110. doi: 10.1016/j.bbmt.2018.04.004. Epub 2018 Apr 10.
2
Does Post-Transplantation Cyclophosphamide Inhibit Graft-versus-Leukemia?移植后环磷酰胺是否抑制移植物抗白血病作用？
Biol Blood Marrow Transplant. 2020 Oct;26(10):e243-e244. doi: 10.1016/j.bbmt.2020.08.010. Epub 2020 Aug 19.
3
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.采用移植后环磷酰胺的T细胞充足的外周血单倍体相合造血细胞移植，在活动性疾病急性髓系白血病中产生的结果与来自传统匹配供体的移植相似。
Biol Blood Marrow Transplant. 2017 Apr;23(4):648-653. doi: 10.1016/j.bbmt.2017.01.068. Epub 2017 Jan 10.
4
Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review.急性髓系白血病患者外周血单倍体相合与匹配无关供者异基因造血细胞移植后的结局比较：一项回顾性单中心研究
Biol Blood Marrow Transplant. 2016 Sep;22(9):1696-1701. doi: 10.1016/j.bbmt.2016.05.010. Epub 2016 May 17.
5
Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.ABO血型不相容对急性髓系白血病单倍体相合造血干细胞移植患者预后的影响——欧洲血液与骨髓移植协会急性白血病工作组的报告
Haematologica. 2017 Jun;102(6):1066-1074. doi: 10.3324/haematol.2016.160804. Epub 2017 Mar 2.
6
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.HLA 不合的单倍体造血干细胞移植后序贯高剂量环磷酰胺治疗的影响。
Biol Blood Marrow Transplant. 2018 Jan;24(1):119-126. doi: 10.1016/j.bbmt.2017.10.002. Epub 2017 Oct 9.
7
Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia.同基因骨髓移植治疗镰状细胞病合并急性髓系白血病 1 例
Pediatr Transplant. 2020 Feb;24(1):e13641. doi: 10.1111/petr.13641. Epub 2019 Dec 27.
8
Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.移植后苯达莫司汀在实验性单倍体相合骨髓移植中可降低移植物抗宿主病（GvHD），同时保留移植物抗白血病效应（GvL）。
Br J Haematol. 2016 Jul;174(1):102-16. doi: 10.1111/bjh.14034. Epub 2016 Mar 31.
9
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis.使用移植后环磷酰胺预防移植物抗宿主病的单倍体相合异基因造血细胞移植治疗多发性骨髓瘤
Biol Blood Marrow Transplant. 2017 Sep;23(9):1549-1554. doi: 10.1016/j.bbmt.2017.05.006. Epub 2017 May 10.
10
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.接受移植后环磷酰胺治疗的HLA匹配和HLA单倍型相同移植后的可比复合终点。
Haematologica. 2017 Feb;102(2):391-400. doi: 10.3324/haematol.2016.144139. Epub 2016 Oct 20.

引用本文的文献

1
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide.外排能力和醛脱氢酶均有助于 CD8+ T 细胞对移植后环磷酰胺的耐药性。
Blood Adv. 2022 Sep 13;6(17):4994-5008. doi: 10.1182/bloodadvances.2022006961.
2
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding.移植后环磷酰胺预防移植物抗宿主病的机制：不断发展的认识。
Front Immunol. 2019 Nov 29;10:2668. doi: 10.3389/fimmu.2019.02668. eCollection 2019.
3
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.
移植后环磷酰胺与环孢素 A 和甲氨蝶呤预防同胞供者移植后移植物抗宿主病。
Blood Adv. 2019 Nov 12;3(21):3351-3359. doi: 10.1182/bloodadvances.2019000236.
4
Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation.MHC单倍型相同小鼠造血细胞移植中移植后环磷酰胺的优化时机
Biol Blood Marrow Transplant. 2020 Feb;26(2):230-241. doi: 10.1016/j.bbmt.2019.09.030. Epub 2019 Oct 2.
5
Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.移植后环磷酰胺通过诱导同种反应性 T 细胞功能障碍和抑制来预防移植物抗宿主病。
J Clin Invest. 2019 Mar 26;129(6):2357-2373. doi: 10.1172/JCI124218.